A flow-cytometric method to investigate glutamate-receptor-sensitivity in whole blood platelets - Results from healthy controls and patients with schizophrenia

Journal of Psychiatric Research

Volumn 43, Issue 6, 2009, Pages 585-591

  Baier, Paul C ^a   Koch, Jakob M ^a   Seeck Hirschner, Mareen ^a   Ohlmeyer, Kathrin ^a   Wilms, Sibylle ^a   Aldenhoff, Josef B ^a   Hinze Selch, Dunja ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Blood platelets; Human; Metabotropic quisqualate receptor; N Methyl d Aspartate (NMDA) receptor; Neuroleptic drugs; Schizophrenia

Indexed keywords

AMISULPRIDE; CHLORPROMAZINE; DIZOCILPINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID;

ADULT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; THROMBOCYTE;

EID: 60949090134     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2008.07.005     Document Type: Article

References (37)

1. Anfossi G., Massucco P., Mularoni E., Cavalot F., Burzacca S., Mattiello L., et al. Studies on the effect of dopamine on the human platelet response. Clinical and Experimental Pharmacology and Physiology 19 (1992) 613-618
2. Belsham B. Glutamate and its role in psychiatric illness. Human Psychopharmacology 16 (2001) 139-146
3. Berk M., Plein H., and Csizmadia T. Supersensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia. International Clinical Psychopharmacology 14 (1999) 119-122
4. Berk M., Plein H., and Ferreira D. Platelet glutamate receptor supersensitivity in major depressive disorder. Clinical Neuropharmacology 24 (2001) 129-132
5. Borges V.C., Nogueira C.W., Zeni G., and Rocha J.B. Organochalcogens affect the glutamatergic neurotransmission in human platelets. Neurochemical Research 29 (2004) 1505-1509
6. Cazenave J., Ohlmann P., Cassel D., Eckly A., Hechler A., and Gachet C. Preparation of washed platelet suspensions from human and rodent blood, platelets and megakaryocytes: volume 1: functional assays (2004), Humana Press, Totowa, NJ pp. 13-28
7. Coyle J.T., and Tsai G. NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia. International Review of Neurobiology 59 (2004) 491-515
8. Da Prada M., Cesura A.M., Launay J.M., and Richards J.G. Platelets as a model for neurones?. Experientia 44 (1988) 115-126
9. Das I., Khan N.S., Puri B.K., Sooranna S.R., de Belleroche J., and Hirsch S.R. Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain. Biochemical and Biophysics Research and Communication 212 (1995) 375-380
10. do Ceu Monteiro M., Sansonetty F., Goncalves M.J., and O'Connor J.E. Flow cytometric kinetic assay of calcium mobilization in whole blood platelets using Fluo-3 and CD41. Cytometry 35 (1999) 302-310
11. do Nascimento C.A., Nogueira C.W., Borges V.C., and Rocha J.B. Changes in [(3)H]-glutamate uptake into platelets from patients with bipolar I disorder. Psychiatry Research 141 (2006) 343-347
12. Essali M.A., Das I., de Belleroche J., and Hirsch S.R. The platelet polyphosphoinositide system in schizophrenia: the effects of neuroleptic treatment. Biological Psychiatry 28 (1990) 475-487
13. Evins A.E., Amico E.T., Shih V., and Goff D.C. Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics. Journal of Neural Transmission 104 (1997) 761-766
14. Felipe A., Vinas O., and Remesar X. Cationic and anionic amino acid transport studies in rat red blood cells. Bioscience Reports 10 (1990) 527-535
15. Fijnheer R., Pietersz R.N., de Korte D., Gouwerok C.W., Dekker W.J., Reesink H.W., et al. Platelet activation during preparation of platelet concentrates: a comparison of the platelet-rich plasma and the buffy coat methods. Transfusion 30 (1990) 634-638
16. Fitzgerald L.W., Deutch A.Y., Gasic G., Heinemann S.F., and Nestler E.J. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. Journal of Neuroscience 15 (1995) 2453-2461
17. Franconi F., Miceli M., Alberti L., Seghieri G., De Montis M.G., and Tagliamonte A. Further insights into the anti-aggregating activity of NMDA in human platelets. British Journal of Pharmacology 124 (1998) 35-40
18. Franconi F., Miceli M., De Montis M.G., Crisafi E.L., Bennardini F., and Tagliamonte A. NMDA receptors play an anti-aggregating role in human platelets. Thrombosis and Haemostasis 76 (1996) 84-87
19. Fumagalli F., Frasca A., Racagni G., and Riva M.A. Dynamic regulation of glutamatergic postsynaptic activity in rat prefrontal cortex by repeated administration of antipsychotic drugs. Molecular Pharmacology 73 (2008) 1484-1490
20. Husain M., Khanna V.K., Roy A., Tandon R., Pradeep S., and Set P.K. Platelet dopamine receptors and oxidative stress parameters as markers of manganese toxicity. Human and Experimental Toxicology 20 (2001) 631-636
21. Maeshima H., Ohnuma T., Sakai Y., Shibata N., Baba H., Ihara H., et al. Increased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophrenia - Juntendo University Schizophrenia Projects (JUSP). Progress in Neuropsychopharmacol and Biological Psychiatry 31 (2007) 1410-1418
22. Mangano R.M., and Schwarcz R. The human platelet as a model for the glutamatergic neuron: platelet uptake of l-glutamate. Journal of Neurochemistry 36 (1981) 1067-1076
23. Möller H., Müller W., and Bandelow B. Neuroleptika: pharmakologische Grundlagen. Klinisches Wissen und Therapeutisches Vorgehen (2001) p. 243
24. Olney J.W., Newcomer J.W., and Farber N.B. NMDA receptor hypofunction model of schizophrenia. Journal of Psychiatry Research 33 (1999) 523-533
25. Priestley T., and Kemp J.A. Kinetic study of the interactions between the glutamate and glycine recognition sites on the N-methyl-d-aspartic acid receptor complex. Molecular Pharmacology 46 (1994) 1191-1196
26. Rijcken C.A., Monster T.B., Brouwers J.R., and den Berg L.T. Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses?. Journal of Clinical Psychopharmacology 23 (2003) 657-659
27. Riva M.A., Tascedda F., Lovati E., and Racagni G. Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs. Brain Research and Molecular Brain Research 50 (1997) 136-142
28. Sargeant P., and Sage S.O. Calcium signalling in platelets and other nonexcitable cells. Pharmacology and Therapeutics 64 (1994) 395-443
29. Shinohe A., Hashimoto K., Nakamura K., Tsujii M., Iwata Y., Tsuchiya K.J., et al. Increased serum levels of glutamate in adult patients with autism. Progress in Neuro-psychopharmacology and Biological Psychiatry 30 (2006) 1472-1477
30. Stahl S.M., and Meltzer H.Y. The human platelet as a model for the dopaminergic neuron: kinetic and pharmacologic properties and the role of amine storage granules. Experimental Neurology 59 (1978) 1-15
31. Suzuki K., Kusumi I., Sasaki Y., and Koyama T. Serotonin-induced platelet intracellular calcium mobilization in various psychiatric disorders: is it specific to bipolar disorder?. Journal of Affective Disorders 64 (2001) 291-296
32. Tan C.H., Lee H.S., Kua E.H., and Peh L.H. Resting and thrombin-stimulated cytosolic calcium in platelets of patients with alcoholic withdrawal, bipolar manic disorder and chronic schizophrenia. Life Science 56 (1995) 1817-1823
33. Tascedda F., Blom J.M., Brunello N., Zolin K., Gennarelli M., Colzi A., et al. Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats. Biological Psychiatry 50 (2001) 117-122
34. Tortorella A., Monteleone P., Fabrazzo M., Viggiano A., De Luca L., and Maj M. Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine. Neuropsychobiology 44 (2001) 167-171
35. Wang Y., Gottlieb M., and Teichberg V.I. An evaluation of erythrocytes as plasma glutamate scavengers for enhanced brain-to-blood glutamate efflux. Neurochemical Research 29 (2004) 755-760
36. Watford M. Net interorgan transport of l-glutamate in rats occurs via the plasma, not via erythrocytes. Journal of Nutrition 132 (2002) 952-956
37. Williams M.S., Coller B.S., Vaananen H.J., Scudder L.E., Sharma S.K., and Marmur J.D. Activation of platelets in platelet-rich plasma by rotablation is speed-dependent and can be inhibited by abciximab (c7E3 Fab; ReoPro). Circulation 98 (1998) 742-748